Loading clinical trials...
Loading clinical trials...
oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tanta University
NCT06026267 · Liver Cirrhosis, Spontaneous Bacterial Peritonitis
NCT04153604 · Cirrhosis, Spontaneous Bacterial Peritonitis
NCT07116369 · Spontaneous Bacterial Peritonitis
NCT06778616 · Spontaneous Bacterial Peritonitis
NCT06679842 · Cirrhosis, Spontaneous Bacterial Peritonitis
Sherief Abd-Elsalam
Tanta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions